Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »
2/321 von 416    DIMDI: MEDLINE (ME60) © NLM
ND: ME10680190
PMID: 10680190
LR: 20041117
CED: 20000317
DCO: 20000317
Autoren: Delafuente JC
Titel: Glucosamine in the treatment of osteoarthritis.
Quelle: Rheumatic diseases clinics of North America; VOL: 26 (1); p. 1-11, vii /200002/
PM: Print
SU: IM
Sprache: English
CY: UNITED STATES
JID: 8708093
ISSN: 0889-857X
CO: RDCAEK
Institution: Department of Pharmacy, School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.
DT: Journal Article; Review
RN: 21
Schlagwörter
CT: COMPLEMENTARY THERAPIES/*; GLUCOSAMINE/*therapeutic use; HUMANS; OSTEOARTHRITIS/*drug therapy
CTG: KOMPLEMENTÄRE THERAPIEVERFAHREN/*; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; OSTEOARTHROSE/*Arzneimitteltherapie
TE: Glucosamine/3416-24-8
CR: 3416-24-8
AB: Glucosamine sulfate, a constituent of cartilage, is evaluated for the treatment of osteoarthritis. Available data suggest that glucosamine decreases pain and improves function in osteoarthritis. Most of the glucosamine studies have methodological flaws or used parenteral formulations, making their data difficult to extrapolate into clinical practice. Glucosamine sulfate is shown to be as good as ibuprofen for osteoarthritis of the knee. Better designed clinical trials of glucosamine are needed to identify its role in the pharmacotherapy of osteoarthritis.
» Volltext »

» Fenster schließen »